Scatter factor induces blood vessel formation in vivo.

Scatter factor (also known as hepatocyte growth factor) is a glycoprotein secreted by stromal cells that stimulates cell motility and proliferation. In vitro, scatter factor stimulates vascular endothelial cell migration, proliferation, and organization into capillary-like tubes. Using two different in vivo assays, we showed that physiologic quantities of purified native mouse scatter factor and recombinant human hepatocyte growth factor induce angiogenesis (the formation of new blood vessels). The angiogenic activity was blocked by specific anti-scatter factor antibodies. Scatter factor induced cultured microvascular endothelial cells to accumulate and secrete significantly increased quantities of urokinase, an enzyme associated with development of an invasive endothelial phenotype during angiogenesis. We further showed that immunoreactive scatter factor is present surrounding sites of blood vessel formation in psoriatic skin. These findings suggest that scatter factor may act as a paracrine mediator in pathologic angiogenesis associated with human inflammatory disease.

[1]  H. Kleinman,et al.  Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. , 1992, Journal of the National Cancer Institute.

[2]  F. Luyten,et al.  Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. , 1992, Experimental cell research.

[3]  R. Halaban,et al.  Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[4]  L. Orci,et al.  Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor , 1991, Cell.

[5]  M. Reiss,et al.  Tumor necrosis factor stimulates epithelial tumor cell motility. , 1991, Cancer research.

[6]  W. Birchmeier,et al.  Evidence for the identity of human scatter factor and human hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Michalopoulos,et al.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. , 1991, Oncogene.

[8]  F. Watt,et al.  Production of scatter factor by ndk, a strain of epithelial cells, and inhibition of scatter factor activity by suramin. , 1991, Journal of cell science.

[9]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[10]  M. Bhargava,et al.  Regulation of motility in bovine brain endothelial cells , 1991, Journal of cellular physiology.

[11]  J. Rubin,et al.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Bhargava,et al.  Interleukin-6 stimulates motility of vascular endothelium. , 1991, EXS.

[13]  H. Kleinman,et al.  Scatter factor stimulates migration of vascular endothelium and capillary-like tube formation. , 1991, EXS.

[14]  M. Bhargava,et al.  Purification, characterization and mechanism of action of scatter factor from human placenta. , 1991, EXS.

[15]  E. Gherardi,et al.  Epithelial scatter factor and development of the chick embryonic axis. , 1990, Development.

[16]  J Vandekerckhove,et al.  Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells , 1990, The Journal of cell biology.

[17]  D. W. Vinter,et al.  Purified Scatter Factor Stimulates Epithelial and Vascular Endothelial Cell Migration , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  U Hübscher,et al.  Efficient production of chicken egg yolk antibodies against a conserved mammalian protein , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  L. Sachs,et al.  Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[21]  M. Okigaki,et al.  Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. , 1989, Biochemical and biophysical research communications.

[22]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[23]  H. Kleinman,et al.  Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro , 1989, Cell.

[24]  E. Gherardi,et al.  Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Voorhees,et al.  Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. , 1989, Journal of the American Academy of Dermatology.

[26]  S. Tatter,et al.  Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. , 1989, Biochemical and biophysical research communications.

[27]  J. Madri,et al.  Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix , 1988, The Journal of cell biology.

[28]  D. Rifkin,et al.  Cell-associated plasminogen activation: regulation and physiological functions. , 1988, Annual review of cell biology.

[29]  W. Birchmeier,et al.  Inhibitory action of transforming growth factor beta on endothelial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Risau,et al.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Michael Stoker,et al.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.

[32]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.

[33]  S. Schwartz,et al.  Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. , 1986, Science.

[34]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Perryman,et al.  An epithelial scatter factor released by embryo fibroblasts. , 1985, Journal of cell science.

[36]  Ferguson Gp,et al.  Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. , 1984 .

[37]  P. Polverini,et al.  Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[38]  P. Coleman,et al.  A SENSITIVE, COUPLED ASSAY FOR PLASMINOGEN ACTIVATOR USING A THIOL ESTER SUBSTRATE FOR PLASMIN * , 1981, Annals of the New York Academy of Sciences.

[39]  A. Polson,et al.  Antibodies to proteins from yolk of immunized hens. , 1980, Immunological communications.